Ruth Malone, RN, PhD, FAAN
Tobacco industry activities aimed at undermining public health, strategic positioning and messaging, marginalized populations, and emerging developments in the social construction of tobacco use.
Jyothi Marbin, MD
Impact of tobacco on low income, urban children and reducing the burden of secondhand smoke on children with focus on the impact of electronic health record changes on clinical uptake of tobacco cessation interventions, as well as the use of online trainings to train physicians on smoking cessation.
Gregory Marcus, MD
Cardiovascular effects of alcohol, atrial fibrillation, supraventricular, implantable cardiac devices with broader interests in clinical research study design and genetic epidemiology.
Michael Matthay, MD
Effects of cigarette smoke and e-cigarette aerosols on susceptibility to acute respiratory distress syndrome (ARDS), a major cause of respiratory failure in critically ill patients.
Wendy Max, PhD
Economic impact of tobacco on health and healthcare expenditures.
Dieter Meyerhoff, PhD
Defining a new MR spectroscopy-based in vivo biomarker of cerebral oxidative stress, which has been associated with chronic smoking and other substance dependence.
Jeremiah Mock, PhD
Dr. Mock conducts collaborative research examining how people’s cultural context shapes their patterns of tobacco use. As a health anthropologist, for over two decades he has focused on examining how and why people’s lived experience of tobacco use and secondhand smoke exposure is deeply rooted in culture, and how cultural and political-economic change can influence the prevalence of tobacco use within a cultural group, as well as changes in people’s modes and norms of tobacco use. His work has recently expanded to examine the cultural phenomena of young people’s pod-based e-cigarette use (e.g., “juuling”), heated tobacco product (e.g., IQOS) use, and cannabis use.
Pages
Center Leadership
Stanton A. Glantz, PhD
Director, Center for Tobacco Research Control & Education
Pamela Ling, MD MPH
Fellowship Program Director
Joe Guydish, PhD
Co-Director, Helen Diller Comprehensive Cancer Center Tobacco Control Program
Research Spotlight
Individuals with mental illness or addictive disorders account for a staggering 44% to 46% of the US tobacco market.
